nicardipine has been researched along with Adenoma, Basal Cell in 4 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to investigate the effect of calcium channel antagonist (nicardipine) on basal and bromocriptine-inhibited GH or PRL secretion in eight patients with pituitary adenomas (six GH producing adenomas and two prolactinomas)." | 7.68 | [Effect of calcium channel antagonist (nicardipine) on growth hormone and prolactin secretion in pituitary adenomas]. ( Hayashi, M; Hosotani, K; Kabuto, M; Katsumura, H; Kobayashi, H; Kubota, T; Nakagawa, T, 1991) |
| "This study was designed to investigate the effect of calcium channel antagonist (nicardipine) on basal and bromocriptine-inhibited GH or PRL secretion in eight patients with pituitary adenomas (six GH producing adenomas and two prolactinomas)." | 3.68 | [Effect of calcium channel antagonist (nicardipine) on growth hormone and prolactin secretion in pituitary adenomas]. ( Hayashi, M; Hosotani, K; Kabuto, M; Katsumura, H; Kobayashi, H; Kubota, T; Nakagawa, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yin, J | 2 |
| Deng, J | 2 |
| Shi, Y | 2 |
| Shu, C | 1 |
| Zeng, ZP | 1 |
| Naruse, M | 1 |
| Guan, BJ | 1 |
| Naruse, K | 1 |
| Sun, ML | 1 |
| Zang, MF | 1 |
| Demura, H | 1 |
| Shi, YF | 1 |
| Kabuto, M | 1 |
| Hayashi, M | 1 |
| Kubota, T | 1 |
| Kobayashi, H | 1 |
| Nakagawa, T | 1 |
| Katsumura, H | 1 |
| Hosotani, K | 1 |
4 other studies available for nicardipine and Adenoma, Basal Cell
| Article | Year |
|---|---|
[The role of Ca2+ in the pathogenesis of human pituitary GH-secreting adenomas].
Topics: Adenoma; Biological Transport, Active; Calcimycin; Calcium; Calcium Channel Blockers; Growth Hormone | 1996 |
The role of calcium ion in the pathogenesis of human pituitary GH-secreting adenomas.
Topics: Adenoma; Biological Transport, Active; Calcium; Calcium Channel Blockers; Growth Hormone; Growth Hor | 1996 |
Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adult; Aldosterone; Endothelins; Female; Humans; H | 1992 |
[Effect of calcium channel antagonist (nicardipine) on growth hormone and prolactin secretion in pituitary adenomas].
Topics: Adenoma; Growth Hormone; Humans; Nicardipine; Pituitary Neoplasms; Prolactin; Prolactinoma | 1991 |